Skip to content

Public FDA record

Z-1045-2009: RELISA ENA Multiparameter Antibody Screening test, enzyme immunoassay test system, manufactured by Immuno

Recall record Z-1045-2009 for Immuno Concepts Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1045-2009
Company in FDA record
Immuno Concepts Inc
FDA classification date
Apr 6, 2009
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

In certain patient samples, it is difficult to properly discriminate between anti-Sm/RMP positive samples and samples that are only anti-Sm positive.

Source facts

Action
The firm has issued telephone calls, e-mails and notification letters to its consignees.
Initiated
2008-11-25
Root cause
Process control
Terminated
2009-11-17
Distribution
Worldwide Distribution including USA, Australia, England, Sweden and Austria.
Recall number
Z-1045-2009
Recall status
Terminated
CDRH record ID
75628
FDA classified
2009-04-06
Recall event number
50519

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗